The uniform increase in the concentration of DCA, the FXR receptor agonist, in bile and stool is consistent with the enhanced expression of FXR target genes such as Nr0b2/Shp and Fgf15 in the ilea of NASH mice. The gene discussed is NR0B2; the disease is metabolic dysfunction-associated steatohepatitis.